Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVRX
DateTimeSourceHeadlineSymbolCompany
02/28/200612:28PMPR Newswire (US)Avalon to Release Fourth Quarter and Full Year 2005 Financial Results on March 7, 2006NASDAQ:AVRX
02/27/20067:00AMPR Newswire (US)Avalon Pharmaceuticals Raises $7.25 Million in Private Placement of Common Stock to Institutional Investors to Support ExpandedNASDAQ:AVRX
02/23/20067:00AMPR Newswire (US)Avalon Pharmaceuticals Appoints William H. Washecka to Its Board of DirectorsNASDAQ:AVRX
02/10/20061:10PMPR Newswire (US)Avalon Pharmaceuticals to Present at BIO CEO & Investor ConferenceNASDAQ:AVRX
02/07/20066:30AMPR Newswire (US)Avalon Pharmaceuticals Completes First Dosing Cycle on First Patient and Initiates Second Cohort of AVN944 Phase I Clinical TriaNASDAQ:AVRX
01/10/20066:00AMPR Newswire (US)Ingenuity Systems Licenses Pathways Analysis Software to Avalon PharmaceuticalsNASDAQ:AVRX
01/09/20066:30AMPR Newswire (US)Avalon Pharmaceuticals Initiates AVN944 Phase I Clinical Trial in Cancer PatientsNASDAQ:AVRX
01/04/20069:45AMPR Newswire (US)Avalon Pharmaceuticals to Present at 24th Annual JPMorgan Healthcare ConferenceNASDAQ:AVRX
12/21/20054:00PMPR Newswire (US)Avalon Pharmaceuticals Announces Expiration of the sanofi-aventis AgreementNASDAQ:AVRX
11/08/20054:30PMPR Newswire (US)Avalon Pharmaceuticals Reports Third Quarter 2005 ResultsNASDAQ:AVRX
11/04/20054:14PMPR Newswire (US)Avalon Pharmaceuticals to Present at Rodman and Renshaw 7th Annual Healthcare ConferenceNASDAQ:AVRX
11/02/200511:44AMPR Newswire (US)Avalon to Release Third Quarter 2005 Financial Results on November 8, 2005NASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/14/200512:45PMPR Newswire (US)Avalon Pharmaceuticals to Present at 2005 BIO InvestorForumNASDAQ:AVRX
09/30/20059:00AMPR Newswire (US)Avalon Pharmaceuticals Announces the Activation of IND for AVN944 for the Treatment of CancerNASDAQ:AVRX
09/29/20059:01AMPR Newswire (US)Avalon Pharmaceuticals Announces Pricing of Initial Public OfferingNASDAQ:AVRX
04/27/200410:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Be Listed on AMEXNASDAQ:AVRX
04/26/200411:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Webcast Presentation at CIBC World Markets Annual Biotechnology & SpecialtyNASDAQ:AVRX
04/19/200411:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:AVRX
04/15/20049:30AMPR Newswire (US)ADVENTRX Pharmaceuticals Receives FDA Clearance for HIV Viral Entry Inhibitor to Begin Phase Ib/IIa Human Clinical TrialNASDAQ:AVRX
04/05/200411:05AMPR Newswire (US)ADVENTRX Pharmaceuticals Announces Definitive Agreement for Sale of Common StockNASDAQ:AVRX
03/11/200410:05AMPR Newswire (US)ADVENTRX Pharmaceuticals Adds Vice President of Clinical and Medical Affairs to Expand Clinical Trial EffortsNASDAQ:AVRX
03/04/20049:35AMPR Newswire (US)ADVENTRX Pharmaceuticals Files IND for Phase Ib/IIa Trials for HIV Viral Entry InhibitorNASDAQ:AVRX
02/24/200410:30AMPR Newswire (US)ADVENTRX Pharmaceuticals Expands Scientific Advisory BoardNASDAQ:AVRX
02/20/200410:30AMPR Newswire (US)ADVENTRX Pharmaceuticals Announces Notice of Government Grant Received by M.D. Anderson Cancer CenterNASDAQ:AVRX
02/17/200410:30AMPR Newswire (US)ADVENTRX Pharmaceuticals Elects New Member to the Board Of DirectorsNASDAQ:AVRX
 Showing the most relevant articles for your search:NASDAQ:AVRX